Related Experiment Video
Updated: May 12, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Cognitive and psychosocial development concerns in children born small for gestational age
Peter A Lee1, Christopher P W Houk
1Department of Pediatrics, Penn State College of Medicine, Milton S. Hershey Medical Center, Hershey, PA 17033-0850, USA. plee@psu.edu
Insights
Infants born small for gestational age (SGA) often experience poorer cognitive function and head growth. Catch-up growth is crucial for better outcomes, though psychosocial development impacts remain unclear.
Area of Science:
- Neonatal Medicine
- Developmental Pediatrics
- Pediatric Endocrinology
Background:
- Infants born small for gestational age (SGA) exhibit poorer cognitive function compared to appropriate for gestational age (AGA) infants.
- Poorer outcomes in SGA infants are linked to smaller size and lack of postnatal catch-up growth, observed from childhood to young adulthood.
- Diminished head circumference at birth and subsequent growth are also associated with adverse outcomes in SGA infants.
Purpose of the Study:
- To review the existing literature on the neurodevelopmental and psychosocial outcomes of infants born small for gestational age (SGA).
- To examine the potential role of growth hormone (GH) therapy in improving outcomes for SGA infants.
- To highlight the limitations and variability in current research regarding SGA outcomes.
Main Methods:
- Systematic review of existing studies on SGA infant outcomes.
- Analysis of cognitive and psychosocial development data in SGA populations.
- Evaluation of studies investigating the effects of growth hormone (GH) therapy on SGA infants.
Main Results:
- Consistent evidence indicates poorer cognitive function in SGA infants compared to AGA peers.
- Growth hormone (GH) therapy has been associated with increased head circumference standard deviation scores in SGA infants.
- The impact of SGA birth on psychosocial development remains largely undetermined.
Conclusions:
- While SGA is linked to poorer cognitive function and head growth, psychosocial outcomes require further investigation.
- Growth hormone (GH) therapy may influence head growth but has not demonstrated clear benefits for cognitive or psychosocial outcomes.
- Current data on SGA outcomes should be interpreted cautiously due to variations in study populations, SGA definitions, and etiology.
Abstract:
Outcome information for infants born small for gestational age (SGA), whether term or premature, suggests poorer cognitive function compared with appropriate size for gestational age (AGA) infants. Poorer outcome is associated with smaller size for gestational age and with lack of catch-up growth after birth. Such data have been reported from early childhood to young adulthood. Diminished head circumference at birth and growth thereafter has also been associated with poor outcome. Based on available reports, the impact of SGA birth upon psychosocial development remains unclear. While it has not been shown that growth hormone (GH) therapy impacts either cognitive or psychosocial outcome, increased head circumference standard deviation scores have been shown to occur with GH therapy. These data need to be interpreted with caution since study populations do not define etiology of SGA and definitions of SGA vary. Further, generalized group data are not applicable to individuals.
Related Concept Videos
Piaget's Stage 1 of Cognitive Development
Exploration...
Socioemotional Development during Infancy
Primary Temperament Types
Stella Chess...
Nature and Nurture
Introduction to Developmental Psychology
Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight psychosocial stages...
Information Processing Approach

